1. Home
  2. FHB vs RCUS Comparison

FHB vs RCUS Comparison

Compare FHB & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Hawaiian Inc.

FHB

First Hawaiian Inc.

HOLD

Current Price

$26.26

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$19.08

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHB
RCUS
Founded
1858
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
FHB
RCUS
Price
$26.26
$19.08
Analyst Decision
Hold
Buy
Analyst Count
6
9
Target Price
$27.50
$28.22
AVG Volume (30 Days)
1.7M
920.9K
Earning Date
01-30-2026
02-25-2026
Dividend Yield
3.95%
N/A
EPS Growth
22.91
N/A
EPS
2.20
N/A
Revenue
$853,588,000.00
$240,000,000.00
Revenue This Year
$6.97
N/A
Revenue Next Year
$3.70
N/A
P/E Ratio
$11.95
N/A
Revenue Growth
7.53
N/A
52 Week Low
$20.32
$6.50
52 Week High
$28.35
$26.40

Technical Indicators

Market Signals
Indicator
FHB
RCUS
Relative Strength Index (RSI) 46.09 36.80
Support Level $26.54 $19.91
Resistance Level $27.42 $21.58
Average True Range (ATR) 0.85 1.19
MACD -0.13 -0.21
Stochastic Oscillator 28.61 2.35

Price Performance

Historical Comparison
FHB
RCUS

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: